Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients
Leukemia
.
2021 Jun;35(6):1820-1822.
doi: 10.1038/s41375-021-01288-0.
Epub 2021 May 18.
Authors
Nikolay Mayanskiy
1
,
Polina Luchkina
2
,
Natalia Fedorova
2
,
Yuri Lebedin
3
,
Natalia Ponomareva
2
Affiliations
1
Russian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia. mayanskiy.nikolay@gmail.com.
2
Russian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia.
3
XEMA Company, Moscow, Russia.
PMID:
34007047
PMCID:
PMC8129958
DOI:
10.1038/s41375-021-01288-0
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antibody Formation
COVID-19*
Child
Disease Outbreaks
Hospitals
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
SARS-CoV-2
Seroconversion